THE PTAB LIVE!
The APJs Speak on Practice, Policy, and Procedure in the World of Pharmaceutical Patent Validity Changes
Jacqueline Bonilla
Deputy Chief Administrative Patent Judge
Patent Trial & Appeal Board
U.S. Patent and Trademark Office
Hon. Susan Mitchell
Lead Judge, Patent Trial & Appeal Board
U.S. Patent and Trademark Office
Hon. Grace Obermann
Administrative Patent Judge, Patent Trial & Appeal Board
U.S. Patent and Trademark Office
Carolyn Blessing
Partner
Locke Lord LLP
- Taking stock of the latest developments related to the PTAB’s expanded use of discretionary denials
- Reviewing the latest stats at PTAB, highlighting bio/pharma cases
- Outlining the latest developments on pilot programs at PTAB
- Legal Experience and Advancement Program (LEAP)
- Fast-Track Appeals
- Motions to Amend (MTAs) in AIA proceedings
- Detailing recent rules at PTAB
- New rule relating to institution of trials (as it relates to SAS, expert testimony, and sur-replies)
- New rule relating to burdens of persuasion in MTAs
- Interpreting PTAB precedent and other information
- Newly designated precedent at PTAB
- New memorandum regarding indefiniteness approach in AIA proceedings